The BCR-ABL negative myeloproliferative neoplasms (MPNs) essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF) including primary myelofibrosis (PMF) and secondary myelofibrosis (SMF) (post-ET MF/post-PV MF) are characterized by uncontrolled clonal proliferation of the hematopoietic stem and progenitor cells [1]. Here, ABL1 is linked to essential thrombocythemia.